EPTIS
BAM Logo

ESEAP: Greek EQA Scheme. Part 5 - HbA1c (Glycosylated Hemoglobin) (In collaboration with EUROREFLAB - Belgium, The Netherlands, Denmark, Finland, Greece and Cyprus)

EPTIS factsheet 138925 | Last revision 2016-11-15 | URL: https://www.eptis.bam.de/pts138925 https://www.eptis.bam.de/pts138925

PT provider
PT provider ESEAP ESEAP
Based in Greece
Language(s) Greek-English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human whole blood, lyophilized Glycosylated hemoglobin (HbA1c) -
Aims of the PT scheme
Target group of participants Clinical Laboratories, POCT testing
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants 105
Accredited or otherwise reviewed by a 3rd party

Accredited by ESYD, the Greek Accreditation Body on the basis of ISO 17043:2010 (Certificate No 820, 18/6/2012)

Recognised by TÜV Hellas on the basis of ISO 9001

Operation is commissioned / requested by
Fees and frequency
Participation fee 300 Euro + VAT
Regularly operated Yes (biweekly)
Year of first operation 2007
Contact details of the PT provider
Provider Contact person
ESEAP
47, Alopekis str.
10676 Athens
Greece

Phone: +30 2107292403
Fax: +30 2103645392
Web: http://www.eseap.gr http://www.eseap.gr
Dr. Otto Panagiotakis
Phone: +30 6978904022
Fax: +30 2103645392
Email: info@eseap.gr info@eseap.gr
If you find any mistakes please contact the responsible EPTIS coordinator in Greece, Ms Vicky Nikou. Ms Vicky Nikou.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21